WHO says it 'strongly supports' Covid booster, reversing previous call

WHO said it is continuing to monitor the global spread of omicron, including a stealth version known as BA.2, which has been documented to have re-infected some people after an initial case of omicron

Topics
World Health Organization | Coronavirus Vaccine | Vaccine

AP  |  Geneva 

An expert group convened by the World Health Organisation said Tuesday it strongly supports urgent and broad access to booster doses, in a reversal of the U.N. agency's previous insistence that boosters weren't necessary and contributed to inequity.

In a statement, WHO said its expert group concluded that immunisation with authorised COVID-19 vaccines provide high levels of protection against severe disease and death amid the global circulation of the hugely contagious omicron variant.

It said vaccination, including the use of boosters, was especially important for people at risk of severe disease.

Last year, WHO's director-general Tedros Adhanom Ghebreyesus called for a moratorium on booster doses while dozens of countries embarked on administering the doses, saying rich countries should immediately donate those vaccines to poor countries instead. WHO scientists said at the time they would continue to evaluate incoming data.

Numerous scientific studies have since proven that booster doses of authorized vaccines help restore waning immunity and protect against serious COVID-19. Booster programs in rich countries including Britain, Canada and the U.S. have been credited with preventing the surge in omicron infections from spilling over into hospitals and cemeteries.

WHO said it is continuing to monitor the global spread of omicron, including a stealth version known as BA.2, which has been documented to have re-infected some people after an initial case of omicron. There's mixed research on whether it causes more severe disease, but vaccines appear just as effective against it.

WHO noted that the current authorized COVID-19 vaccines are all based on the strain that was first detected in Wuhan, China more than three years ago.

Since then, there has been continuous and substantial virus evolution and it is likely that this evolution will continue, resulting in the emergence of new variants, the agency said. It added that vaccines would likely need to be updated.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on World Health Organization
First Published: Tue, March 08 2022. 20:09 IST
RECOMMENDED FOR YOU